Dr. Shroff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3838 N Campbell Ave Unit 10
Tucson, AZ 85719Phone+1 314-853-1185
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2004
Certifications & Licensure
- AZ State Medical License 2018 - 2025
- TX State Medical License 2007 - 2024
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer Start of enrollment: 2021 Oct 12
Roles: Principal Investigator, Contact
- Immune Response to the COVID-19 Vaccine Start of enrollment: 2021 Jun 07
- Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsMolecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo
Journal of the National Cancer Institute. 2023-07-06 - 520 citationsPancreatic cancer.Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff
Lancet. 2020-06-27 - 17 citationsBRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtypeHumaid O. Al-Shamsi, Deepa Anand, Rachna T. Shroff, Apurva Jain, Mingxin Zuo
Journal of Gastrointestinal Oncology. 2016-08-01
Press Mentions
- Miniature Organs Driving Precision Medicine and New Drug DiscoveryApril 21st, 2023
- What Can Be Learned from Negative Findings of Two Trials in Biliary Tract CancerFebruary 7th, 2023
- 'More Is Not Better' in Two First-Line Trials for Biliary Tract CancerJanuary 22nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: